股本结构
单位：万股
| 公告日期 | 2023-08-07 | 2023-08-07 | 2023-05-22 | 2023-05-09 | 2023-03-14 | 2022-11-10 |
|---|---|---|---|---|---|---|
| 证券总股本 | 251.45 | 250.21 | 250.19 | 3252.48 | 3246.67 | 3245.67 |
| 普通股本 | 251.45 | 250.21 | 250.19 | 3252.48 | 3246.67 | 3245.67 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-08-01 | 2023-06-30 | 2023-05-23 | 2023-03-31 | 2022-12-31 | 2022-11-01 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2023-08-07 | 251.45 | 未披露 | 定期报告 | 2023-08-01 |
| 2023-08-07 | 250.21 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock upon exercise of stock options
|
2023-06-30 |
| 2023-05-22 | 250.19 | 未披露 |
更多>>
Sigilon Therapeutics, Inc. announced it will effect a one-for-13 reverse stock split of its issued and outstanding common stock.
|
2023-05-23 |
| 2023-05-09 | 3252.48 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-14 | 3246.67 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock upon exercise of stock options
Issuance of ESPP shares
Issuance of common stock upon vesting of restricted stock units
|
2022-12-31 |
| 2022-11-10 | 3245.67 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-11-10 | 3245.42 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock upon vesting of restricted stock units
Issuance of ESPP shares
|
2022-09-30 |
| 2022-05-12 | 3239.93 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock upon exercise of stock options
Issuance of ESPP shares
|
2022-03-31 |
| 2022-03-14 | 3236.07 | 未披露 | 定期报告 | 2022-03-01 |
| 2022-03-14 | 3235.99 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock upon exercise of stock options
Issuance of ESPP shares
|
2021-12-31 |
| 2021-11-10 | 3230.93 | 未披露 | 定期报告 | 2021-11-01 |
| 2021-11-10 | 3220.13 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock upon exercise of stock options
|
2021-09-30 |
| 2021-08-10 | 3205.73 | 未披露 | 定期报告 | 2021-07-31 |
| 2021-08-10 | 3186.40 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of stock options
|
2021-06-30 |
| 2021-05-10 | 3152.97 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-04-27 | 3152.95 | 未披露 | 定期报告 | 2021-04-26 |
| 2021-05-10 | 3150.20 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of common stock upon exercise of stock options
|
2021-03-31 |
| 2021-03-18 | 3149.26 | 未披露 | 定期报告 | 2021-03-12 |
| 2021-03-18 | 3146.50 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of convertible preferred stock, net of issuance costs of $127
Conversion of convertible preferred stock to common stock
Cashless exercise of warrants
Issuance of common stock in connection with the initial public offering, net of underwriter discounts and issuance costs of $13,058
Issuance of common stock upon exercise of stock options
|
2020-12-31 |
| 2020-12-07 | 3019.03 | 未披露 |
更多>>
1.Common stock offered by the company 7,000,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 5,463,170 shares of common stock outstanding as of October 31, 2020
|
2020-12-04 |
From March 31, 2023 to June 30, 2023
Issuance of common stock upon exercise of stock options
Sigilon Therapeutics, Inc. announced it will effect a one-for-13 reverse stock split of its issued and outstanding common stock.
From December 31, 2021 to December 31, 2022
Issuance of common stock upon exercise of stock options
Issuance of ESPP shares
Issuance of common stock upon vesting of restricted stock units
From June 30, 2022 to September 30, 2022
Issuance of common stock upon vesting of restricted stock units
Issuance of ESPP shares
From December 31, 2021 to March 31, 2022
Issuance of common stock upon exercise of stock options
Issuance of ESPP shares
From December 31, 2020 to December 31, 2021
Issuance of common stock upon exercise of stock options
Issuance of ESPP shares
From June 30, 2021 to September 30, 2021
Issuance of common stock upon exercise of stock options
From March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of stock options
From December 31, 2020 To March 31, 2021
Issuance of common stock upon exercise of stock options
from December 31, 2019 to December 31, 2020
Issuance of convertible preferred stock, net of issuance costs of $127
Conversion of convertible preferred stock to common stock
Cashless exercise of warrants
Issuance of common stock in connection with the initial public offering, net of underwriter discounts and issuance costs of $13,058
Issuance of common stock upon exercise of stock options
1.Common stock offered by the company 7,000,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 5,463,170 shares of common stock outstanding as of October 31, 2020